Scarica l'app Stockscreener
3.96
2.22%
-0.09
Pre-mercato:
3.95
-0.010
-0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Altimmune Inc Borsa (ALT) Ultime notizie
Will Altimmune Inc. stock reach all time highs in 2025Market Performance Recap & Safe Entry Momentum Tips - newser.com
Technical analysis overview for Altimmune Inc. stockJuly 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com
Why Altimmune Inc. stock is a value investor pickQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com
Altimmune completes enrollment for alcohol use disorder trial - Investing.com
Altimmune (ALT) Completes Enrollment for Phase 2 AUD Trial - GuruFocus
Does Altimmune Inc. show high probability of reboundJuly 2025 Outlook & Fast Entry and Exit Trade Plans - newser.com
Altimmune Completes Patient Enrollment Ahead of Schedule in Phase 2 Clinical Trial for Pemvidutide in Alcohol Use Disorder - Quiver Quantitative
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder - The Manila Times
Should you wait for a breakout in Altimmune Inc.Stop Loss & Low Drawdown Investment Strategies - newser.com
Altimmune Inc. stock chart pattern explainedQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
How strong is Altimmune Inc. stock revenue growthGlobal Markets & Weekly Momentum Stock Picks - newser.com
Using AI based signals to follow Altimmune Inc.July 2025 Momentum & Safe Investment Capital Preservation Plans - newser.com
Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of "Hold" from Brokerages - MarketBeat
How Altimmune Inc. stock performs during Fed tightening cyclesMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - newser.com
How to use Fibonacci retracement on Altimmune Inc.Quarterly Trade Report & High Accuracy Swing Trade Signals - newser.com
Altimmune (ALT) to Release Quarterly Earnings on Thursday - MarketBeat
Tools to monitor Altimmune Inc. recovery probability2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
Automated trading signals detected on Altimmune Inc.2025 Volume Leaders & Safe Capital Growth Trade Ideas - newser.com
Moody Aldrich Partners LLC Invests $610,000 in Altimmune, Inc. $ALT - MarketBeat
Can technical indicators confirm Altimmune Inc.’s reversalMarket Risk Report & Weekly High Return Stock Opportunities - newser.com
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding - GlobeNewswire Inc.
Forecasting Altimmune Inc. price range with options dataFed Meeting & Risk Managed Investment Entry Signals - newser.com
How to forecast Altimmune Inc. trends using time seriesWatch List & Free Risk Controlled Daily Trade Plans - newser.com
What technical charts say about Altimmune Inc. stockQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com
What MACD and RSI say about Altimmune Inc.2025 Market Trends & Detailed Earnings Play Strategies - newser.com
Using fundamentals and technicals on Altimmune Inc.Risk Management & Community Consensus Stock Picks - newser.com
Can momentum traders help lift Altimmune Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - newser.com
Altimmune: Competitor Buyouts Plus Regulatory And Clinical Progress (NASDAQ:ALT) - Seeking Alpha
Altimmune (Nasdaq: ALT) schedules Nov 6 results call at 8:30 a.m. ET with business update - Stock Titan
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):